Public research preview
Perbandt, Uwe, Vorstand of Viromed Medical AG
Disclosed a buy transaction in Viromed Medical AG. Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- BaFin managers' transactions
- Published
- 2 Jun 2026, 09.19
- Parser confidence
- 96%
- Instrument mapping
- 85%
- Filing delay
- 5 days
Timeline
Transaction date
27 May 2026
Public disclosure
1 Jun 2026
Now
Tracked today
Filing delay: 5 days
Price movement
Fallback coverage
- Provider
- Fixture market data
- Fetched
- 2 Jun 2026
No free fixture-market price coverage for DE000A40ZVN7 / VME.
Daily stock-price history is unavailable for this signal.
- Fallback transaction price
- 6,6
- Fallback disclosure price
- 6,6
- Fallback latest price
- 6,6
- Pre-disclosure move
- 0.0%
- Post-disclosure move
- 0.0%
- Market-adjusted move
- 0.0%
Why Copy Window is Still fresh
Supporting factors
- Parsed buy disclosure for ordinary shares from BaFin managers' transactions.
- Transaction value is EUR 13,200.
- Post-disclosure move is calculated from Fixture market data daily closes.
Cautions
- Market-price coverage is fixture-backed until a free public provider is connected.
- Review the original source document before making any investment decision.
Source document
BaFin managers' transactions, published 2 Jun 2026, 09.19
- Parser confidence
- 96%
- Instrument mapping
- 85%